These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32770981)

  • 41. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
    Tan Y; Zhou G; Wang X; Chen W; Gao H
    Int J Oncol; 2018 Jul; 53(1):371-383. PubMed ID: 29749454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer.
    Chen Y; Liu F; Wu K; Wu W; Wu H; Zhang W
    J Gene Med; 2018 Dec; 20(12):e3056. PubMed ID: 30225951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
    Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
    Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.
    Ye G; Lu Q; Zhao W; Du D; Jin L; Liu Y
    Tumour Biol; 2014 Nov; 35(11):11261-7. PubMed ID: 25113250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma.
    Kobayashi I; Semba S; Matsuda Y; Kuroda Y; Yokozaki H
    Pathobiology; 2006; 73(1):8-17. PubMed ID: 16785763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-Cadherin-Mediated Activation of PI3K/Akt-GSK-3β Signaling Attenuates Nucleus Pulposus Cell Apoptosis Under High-Magnitude Compression.
    Li P; Liang Z; Hou G; Song L; Zhang R; Gan Y; Zhang C; Xu Y; Zhou Q
    Cell Physiol Biochem; 2017; 44(1):229-239. PubMed ID: 29131030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of the PI3K/Akt pathway in estrogen-mediated regulation of human CYP7B1: identification of CYP7B1 as a novel target for PI3K/Akt and MAPK signalling.
    Tang W; Pettersson H; Norlin M
    J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):63-73. PubMed ID: 18790053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
    Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
    Zheng J; Dai X; Chen H; Fang C; Chen J; Sun L
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1108-1114. PubMed ID: 29944886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lentivirus media miR-1246 knockdown inhibits tumor growth and promotes apoptosis of SiHa cells].
    Du P; Lai YH; Yao DS; Lu Y; Chen JY; Ding N
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):481-486. PubMed ID: 30078258
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AFAP1-AS1 Promotes Proliferation of Pituitary Adenoma Cells through miR-103a-3p to Activate PI3K/AKT Signaling Pathway.
    Tang H; Zhu D; Zhang G; Luo X; Xie W
    World Neurosurg; 2019 Oct; 130():e888-e898. PubMed ID: 31299308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.